Эндокардиальная имплантация левожелудочкового электрода для кардиоресинхронизирующей терапии
Е. Б. Кропоткин, Э. А. Иваницкий, В.А. Сакович et al. · Сибирский журнал клинической и экспериментальной медицины · 2015
The aim of the study was to assess efficacy and safety of cardiac resynchronization therapy, where the left ventricle lead was implanted endocardially. Data of 10 consecutive patients were analyzed.
Cited by 0 works. doi:10.29001/2073-8552-2015-30-1-101-105
Authors
References
- Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices
- Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure
- Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients
- Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety
- Epicardial Activation of Left Ventricular Wall Prolongs QT Interval and Transmural Dispersion of Repolarization
- Mid‐term Follow‐Up of Endocardial Biventricular Pacing
- Left Ventricular Lead Insertion Using a Modified Transseptal Catheterization Technique: A Totally Endocardial Approach for Permanent Biventricular Pacing in End‐Stage Heart Failure
- Potential Proarrhythmic Effects of Biventricular Pacing
- Left Ventricular Endocardial Pacing Improves Resynchronization Therapy in Canine Left Bundle-Branch Hearts
- Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery